Xeris Biopharma (XERS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.The power ...

Verona Pharma PLC American Depositary Share (VRNA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tra ...

投资计划 - 公司宣布投资1.95亿美元扩建位于伊利诺伊州北芝加哥的原料药(API)生产设施 [1] - 该投资是公司此前承诺在美国投资超过100亿美元资本计划的一部分 [1][8] - 新设施将增强公司在神经科学、免疫学和肿瘤学领域的化学合成能力 [2] 生产扩张 - 新API设施将于2025年秋季开始建设，预计2027年全面投产 [3] - 扩建将支持当前和下一代药物的美国本土生产 [2] - 未来十年公司计划扩大在美国的API、药品、多肽和医疗器械生产 [3] 就业影响 - 公司在美国11个生产基地支持超过6000个工作岗位 [3] - 扩建将为北芝加哥创造更多就业机会 [8] - 公司在伊利诺伊州总部拥有超过11000名员工 [4] 战略意义 - 扩建旨在保持美国在制药创新领域的领导地位 [3] - 投资将加强美国关键制造能力和产能 [1] - 项目将巩固伊利诺伊州的生物制造生态系统 [5] 公司背景 - 公司专注于免疫学、肿瘤学、神经科学和眼科等关键治疗领域 [6] - 致力于开发和提供解决重大健康问题的创新药物 [6] - 拥有Allergan医美产品组合 [6]

I'm a Ukraine-based seasoned investor, who firsthand experienced what’s it like to live in an environment full of systemic geopolitical shocks when the war came to my home country. Despite this, I managed to build an all-weather portfolio that has been able to thrive in volatile markets. My goal is to help investors find event-driven geopolitical ideas that can generate strong returns during periods of economic and political uncertainty.Analyst’s Disclosure:I/we have a beneficial long position in the shares ...

Hong Kong, China, Aug. 12, 2025 (GLOBE NEWSWIRE) -- In today's fast-paced work environment, the efficient and accurate transmission of information has become a core requirement for improving communication quality and work efficiency. To meet this demand, a new AI text visualization tool called PicDoc has been developed. PicDoc, named after the combination of "Picture" and "Document", defines the mission of visualizing ideas - as easy as taking a photo to capture a moment, and as fast as generating a picture ...

Allschwil, Switzerland – August 12, 2025Idorsia Ltd (SIX: IDIA) announced today that The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, has nominated TRYVIO™ (aprocitentan) in the category of “Best Pharmaceutical Product” in the 2025 Prix Galien USA awards. The winner will be announced during the Prix Galien USA Awards Ceremony on October 30, 2025. To qualify for the Prix Galien Award, each candidate must be US Food and Drug Administration (FDA) approved ...

Sotherly Hotels Inc. (NASDAQ:SOHO) Q2 2025 Earnings Conference August 12, 2025 10:00 AM ET Company Participants Andrew Mack Sims - Vice President of Operations & Investor Relations Anthony E. Domalski - VP, Secretary & CFO David R. Folsom - President, CEO & Director Scott M. Kucinski - Executive VP & COO Conference Call Participants Alexander David Goldfarb - Piper Sandler & Co., Research Division Operator Good morning all, and thank you for joining us for the Sotherly Hotels Q2 2025 Conference Call and Web ...

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York. As a journalist, he has covered every futures market traded in the U.S., at one time or another. Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a ...

财报发布时间及预期 - Amcor Plc (AMCR) 计划于8月4日公布2025财年第四季度财报 [1] - 第四季度收入共识预期为51.7亿美元 同比增长46.3% [1] - 每股收益共识预期为0.21美元 与去年同期持平 过去60天下调4.6% [1] 盈利预测趋势 - 当前季度(Q1)每股收益预期为0.21美元 过去60天下降4.55% [2] - 全年(F1)每股收益预期保持0.73美元 60天内无变化 [2] - 公司过去四个季度盈利均符合市场预期 平均偏差为0% [3] 业务板块表现预测 - 第四季度总销量预计增长0.3% 主要由软包装业务驱动 [4] - 硬包装业务销售额预计下降10.6% 受销量下滑和价格组合不利影响 [4] - 软包装业务销量预计增长1% 销售额预计达27.1亿美元 同比增长1.1% [8] - 硬包装业务销量预计下降2% 价格组合下降1% 销售额预计7.6亿美元 [9] 历史销量表现 - 公司销量连续七个季度负增长后 在2024财年第四季度恢复1%增长 [6] - 2025财年前两季度销量均增长2% 第三季度持平 [6] - 原材料供应短缺和价格波动预计影响第四季度业绩 [7] 股价表现 - 过去一年Amcor股价下跌3.5% 同期行业指数下跌5.8% [10] 同业公司表现 - Sealed Air第二季度每股收益0.89美元 超预期 同比增长7% [12] - Packaging Corp第二季度每股收益2.48美元 超预期 同比增长13% [14] - Avery Dennison第二季度每股收益2.42美元 超预期 但收入同比下降0.7% [15]

Madison Square Garden Sports Corp. (NYSE:MSGS) Q4 2025 Earnings Conference August 12, 2025 10:00 AM ET Company Participants Ari Danes - Senior Vice President of Investor Relations & Treasury Jamaal T. Lesane - Chief Operating Officer Victoria M. Mink - Executive VP, CFO & Treasurer Conference Call Participants Brandon A Ross - LightShed Partners, LLC David Carl Joyce - Seaport Research Partners Joseph Robert Stauff - Susquehanna Financial Group, LLLP, Research Division Peter Lawler Supino - Wolfe Research, ...